This increased aggregation potential has made Aβ42 the focus of theories about Alzheimer’s pathology. The amyloid cascade ...

Researchers from Washington University in St. Louis found people who took suvorexant, a common treatment for insomnia, for ...

Eisai believes the trial results prove a longstanding theory that removal of sticky deposits of a protein called amyloid beta from the brains of people with early Alzheimer’s can delay its advance.

As for “the amyloid work” – for decades, the geneticist and molecular biologist has taken “a lot of flak” for a theory that has now been proven. Until three years ago, he was accustomed ...

According to the National Institutes of Health, 30-50% of brains donated to research as “controls” or healthy end up having ...